HHealthcare Read More NewLimit ‘close’ to clinic-ready epigenetic reprogramming therapyNovember 28, 2025 Liver rejuvenation program produces a ‘lead payload’ as biotech begins its journey towards human clinical trials. After several…
HHealth Read More Obesity-related metabolic stress may affect brain health far earlier than expectedNovember 26, 2025 For decades, scientists have known that what harms the body often harms the brain. Conditions such as obesity,…
HHealth Read More New signaling molecule drives development of tissue resident memory T cellsNovember 23, 2025 We owe a lot to tissue resident memory T cells (TRM). These specialized immune cells are among the…
HHealth Read More Blood group A linked to a higher risk of primary biliary cholangitisNovember 19, 2025 A major retrospective study shows that people with blood group A face a higher likelihood of autoimmune liver…
HHealth Read More Study explores how elevated growth hormone levels contribute to liver agingNovember 18, 2025 A new research paper was published in Volume 17, Issue 10 of Aging-US on October 3, 2025, titled “Growth hormone excess…
HHealth Read More Understanding leptin’s dual function in MAFLD pathogenesisNovember 14, 2025 Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, intricately linked with…
HHealth Read More Switching APOE4 to APOE2 in adult mice reduces Alzheimer’s pathology and improves memoryNovember 12, 2025 By flipping a single genetic switch from APOE4 to APOE2 in adult mice, researchers reversed key Alzheimer’s-like changes…
HHealth Read More Study clarifies how biliary atresia overlaps with multiple congenital syndromesNovember 12, 2025 Biliary atresia (BA) represents one of the leading causes of pediatric liver failure, often requiring surgical intervention or…
HHealth Read More One-time CRISPR therapy safely lowers cholesterol and triglycerides in early trialNovember 11, 2025 In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and…
HHealth Read More Low-dose THC mitigates harmful side effects and inflammation caused by HIV treatmentNovember 6, 2025 Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy…
HHealth Read More Inconsistent labels and risky doses found in turmeric supplements worldwideNovember 4, 2025 An new study reveals major gaps in the regulation and transparency of turmeric supplements, highlighting how weak oversight…
HHealth Read More Early elevation of complement-related proteins in metabolic dysfunction-associated steatotic liver disease (MASLD) with normal liver enzymes | BMC GastroenterologyOctober 29, 2025 Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence…